Bexsero, Injektionssuspension

7680657300031 CH-65730 Injektionssuspension
Bexsero, Injektionssuspension
Bexsero, Injektionssuspension
Bexsero, Injektionssuspension
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/06/2025
Summary of Product Characteristics
Français
26/06/2025
Summary of Product Characteristics
Italien
26/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
0.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.2 MG Substance HBESI

Reimbursement information

Public price
CHF 101.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/01/2023

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
65730
Drug name
Bexsero, Injektionssuspension
Galenic form
INJFS
ATC Code
J07AH09
Authorization status
Z
Dispensing category
B
First authorization
23/11/2017
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken-Meningitis der Serogruppe B

Package details

Description (FR)
BEXSERO susp inj ser pré 0.5 ml
Description (DE)
BEXSERO Inj Susp Fertspr 0.5 ml
Market launch
23/11/2017
Narcotic (BTM)
No

Other package sizes (2)

BEXSERO susp inj (#) ser pré 0.5 ml
None None
GTIN: 7680657300017
Not in V1
BEXSERO sol inj 50 µg 10 pce
10 FESP
GTIN: 7680657300048
Not in V1